Picture loading failed.

Pre-Made Vantictumab biosimilar, Whole Mab: Anti-FZD Family therapeutic antibody is a biosimilar expressed by mammalian cell line as a benchmark reference therapeutic antibody for biological drug disovery items including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.

Vantictumab is a human IgG2 monoclonal antibody designed for the treatment of cancer.

Order information


* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry

Catalog No. Package Price(In USD) Qty (Quantity) Sum(In USD)
GMP-Bios-ab-611-1mg 1mg 3090
GMP-Bios-ab-611-10mg 10mg Inquiry
GMP-Bios-ab-611-100mg 100mg Inquiry
GMP-Bios-ab-611-xmg >100mg Inquiry
Shipping Cost: 760.00
Total:



Description

Products Name (INN Index) Pre-Made Vantictumab biosimilar, Whole Mab: Anti-FZD Family therapeutic antibody
INN Name Vantictumab
TargetFZD Family
FormatWhole mAb
DerivationHuman
Species ReactivityHuman
CH1 IsotypeIgG2
VD LCLambda
Highest_Clin_Trial (Jan '20)Phase-I
Est. StatusDiscontinued
100% SI StructureNone
99% SI StructureNone
95-98% SI StructureNone
Year Proposed2013
Year Recommended2014
CompaniesBayer HealthCare Pharmaceuticals;OncoMed Pharmaceuticals
Conditions Approvedna
Conditions Activena
Conditions DiscontinuedBreast cancer;Non-small cell lung cancer;Pancreatic cancer
Development TechMorphoSys HuCAL Phage Display